Cargando…

Research of Pathogenesis and Novel Therapeutics in Arthritis

Arthritis has a high prevalence globally and includes over 100 types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in th...

Descripción completa

Detalles Bibliográficos
Autor principal: Tang, Chih-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479975/
https://www.ncbi.nlm.nih.gov/pubmed/30987068
http://dx.doi.org/10.3390/ijms20071646
_version_ 1783413469417046016
author Tang, Chih-Hsin
author_facet Tang, Chih-Hsin
author_sort Tang, Chih-Hsin
collection PubMed
description Arthritis has a high prevalence globally and includes over 100 types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis, but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for these patients. In this editorial, the twenty articles published in the Special Issue Research of Pathogenesis and Novel Therapeutics in Arthritis 2019 are summarized and discussed as part of the global picture of the current understanding of arthritis.
format Online
Article
Text
id pubmed-6479975
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64799752019-04-29 Research of Pathogenesis and Novel Therapeutics in Arthritis Tang, Chih-Hsin Int J Mol Sci Editorial Arthritis has a high prevalence globally and includes over 100 types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis, but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for these patients. In this editorial, the twenty articles published in the Special Issue Research of Pathogenesis and Novel Therapeutics in Arthritis 2019 are summarized and discussed as part of the global picture of the current understanding of arthritis. MDPI 2019-04-02 /pmc/articles/PMC6479975/ /pubmed/30987068 http://dx.doi.org/10.3390/ijms20071646 Text en © 2019 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Tang, Chih-Hsin
Research of Pathogenesis and Novel Therapeutics in Arthritis
title Research of Pathogenesis and Novel Therapeutics in Arthritis
title_full Research of Pathogenesis and Novel Therapeutics in Arthritis
title_fullStr Research of Pathogenesis and Novel Therapeutics in Arthritis
title_full_unstemmed Research of Pathogenesis and Novel Therapeutics in Arthritis
title_short Research of Pathogenesis and Novel Therapeutics in Arthritis
title_sort research of pathogenesis and novel therapeutics in arthritis
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479975/
https://www.ncbi.nlm.nih.gov/pubmed/30987068
http://dx.doi.org/10.3390/ijms20071646
work_keys_str_mv AT tangchihhsin researchofpathogenesisandnoveltherapeuticsinarthritis